Prevalence, determi- nants, and clinical significance of masked hypertension in a popula- tion-based sample of African Americans: the Jackson Heart Study. Am J Hypertens. 2015;28:900 8. S4.4-33. Andalib A, Akhtari S, Rigal R, et al. Determinants of masked hyper- tension in hypertensive patients treated in a primary care setting. Intern Med J. 2012;42:260 6. S4.4-34. Terawaki H, Metoki H, Nakayama M, et al. Masked hypertension determined by self-measured blood pressure at home and chronic kidney disease in the Japanese general population: the Ohasama study. Hypertens Res. 2008;31:2129 35. 5. Causes of Hypertension 5.1. Genetic Predisposition S5.1-1. Kaplan NM. Primary hypertension: pathogenesis. In: Kaplan's Clinical Hypertension. Philadelphia, PA: Lippincott Williams & Wilkins; 200650 121. S5.1-2. Padmanabhan S, Caulfield M, DominiczakAF. Genetic and molecu- lar aspects of hypertension. Circ Res. 2015;116:937 59. S5.1-3. Lifton RP, Gharavi AG, Geller DS. Molecular mechanisms of human hypertension. Cell. 2001;104:545 56. S5.1-4. Dominiczak AF, Kuo D. Hypertension: update 2017. Hypertension. 2017;69:3 4. S5.1-5. Ference BA, Julius S, Mahajan N, et al. Clinical effect of natu- rally random allocation to lower systolic blood pressure beginning before the development of hypertension. Hypertension. 2014;63: 1182 8. 5.2. Environmental Risk Factors S5.2-1. Savica V, Bellinghieri G, Kopple JD. The effect of nutrition on blood pressure. Annu Rev Nutr. 2010;30:365 401. S5.2-2. Chan Q, Stamler J, Griep LMO, et al. An update on nutrients and blood pressure. J Atheroscler Thromb. 2016;23:276 89. S5.2-3. Tang WHW, Kitai T, Hazen SL. Gut microbiota in cardiovascular health and disease. Circ Res. 2017;120:1183 96. 5.2.1. Overweight and Obesity S5.2.1-1. Bray GA. Life insurance and overweight. Obes Res. 1995;3:97 9. S5.2.1-2. Harsha DW, Bray GA. Weight loss and blood pressure control (Pro). Hypertension. 2008;51:1420 5; discussion 1425. S5.2.1-3. Hubert HB, Feinleib M, McNamara PM, et al. 